熱門資訊> 正文
Sage Therapeutics申请2.5亿美元普通股
2024-09-18 03:36
- Sage Therapeutics (NASDAQ:SAGE) filed a prospectus for the offer and sale of $250M of its common stock.
- The company also filed for a mixed securities shelf.
- Filing
More on Sage Therapeutics
- Sage Therapeutics, Inc., (SAGE) Q2 2024 Earnings Call Transcript
- Sage Therapeutics: Tremors Of Trouble, But PPD Progress (Rating Downgrade)
- Sage Therapeutics Q2 2024 Earnings Preview
- Sage adds another downgrade as TD Cowen cuts after mid-stage setback
- Seeking Alpha’s Quant Rating on Sage Therapeutics
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
